Market Research Logo

Asia-Pacific Clinical Nutrition Market - Segmented by Route of Administration, Disease Type, End-user, and Geography - Growth, Trends, and Forecast (2018 - 2023)

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Prevalence of Metabolic Disorders
6.1.2 High Spending on Healthcare
6.2 Market Restraints
6.2.1 Unwillingness of Hospitals and In-House Pharmacies/Dispencaries to Maintain the Required Stock of Clinical Nutrition Products
6.2.2 Heterogenous Nature of Government Coverage/Reimbursement across Countries
6.2.3 Imprecise Perception about Clinical Nutrition
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Route Of Administration
7.1.1 Oral
7.1.2 Enteral
7.1.3 Parenteral
7.2 By Disease Type
7.2.1 Nutritional Support in Cancer
7.2.2 Nutritional Support in Gastrointestinal (Gi) Diseases
7.2.3 Nutritional Support in Neurological Diseases
7.2.4 Nutritional Support in Renal Diseases
7.2.5 Nutritional Support in Respiratory Diseases
7.3 By End User
7.3.1 Infant
7.3.2 Child
7.3.3 Adult
7.3.4 Geriatric
7.4 By Geography
7.4.1 Asia-Pacific
7.4.1.1 China
7.4.1.2 Japan
7.4.1.3 India
7.4.1.4 Australia & New Zealand
7.4.1.5 South Korea
7.4.1.6 Rest of Asia-Pacific
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Abbott Nutrition
9.2 Baxter Healthcare
9.3 Braun Melsungen Ag
9.4 Fresenius Kabi
9.5 Mead Johnson
9.6 Nestle Health Science
9.7 Nutricia
9.8 Perrigo Company Plc
*List Not Exhaustive
10. Future of the Market

Asia-Pacific Clinical Nutrition Market - Segmented by Route of Administration, Disease Type, End-user, and Geography - Growth, Trends, and Forecast (2018 - 2023)

The Asia-Pacific clinical nutrition market is expected to register a CAGR of 7.9%, during the forecast period, 2018 to 2023. Clinical nutrition is an area of medicine that offers treatment of medical disorders caused due to an improper diet or due to the body’s inability to absorb the nutrients available in a normal diet. Clinical nutrition products include clinical foods and dietary supplements that are categorized primarily as pharmaceuticals and are delivered through enteral and parenteral feeding. They are aimed at treating metabolic disorders, eating or nutritional disorders, and others.

Increasing Prevalence of Metabolic Disorders

The prevalence of metabolic disorders has increased over the past decade; however, this is only in terms of raw data. The actual number of patients going for the diagnosis of metabolic disorders has increased over the decade, hence, an increase in the number of patients diagnosed. Most of the metabolic syndromes result in situations where body lacks the capability to synthesize non-essential molecules, like vitamins, amino acids, and several molecules involved in metabolic pathways. Most of these conditions can be managed only with supplementation of one or two nutrients. For instance, vitamin D deficiency can be managed simply by using vitamin D tablets. But, the market is large, owing to metabolic disorders that last for a lifetime. Hence, once diagnosed, a patient becomes a lifelong customer, thus, compensating the low cost of single units. This, combined with increase in the number of patients being diagnosed with metabolic syndromes, is driving the growth of the clinical nutrition market. The other factor, such as high spending on healthcare is driving the Asia-Pacific clinical nutrition market.

Unwillingness of Hospitals and In-house Pharmacies/Dispencaries to Maintain the Required Stock of Clinical Nutrition Products

Unlike developed nations, like United States or European countries, where the regulators can mandate maintaining stocks of some products in in-house pharmacies/dispensaries, along with retail pharmacies, no such regulation exists in emerging markets and third-world countries. This leaves maintaining the stock of any product at the sole discretion of people running the pharmacies/dispensaries (both in-house and retail). As a result, the owners of pharmacies and dispensaries mostly prefer to maintain the stocks of products that have quick turnaround. This results in the products, such as clinical nutrition or anti-venoms, being rarely kept in stock in the pharmacies/dispensaries, owing to high turnaround time for clinical nutrition products and the doctors in emerging and third world countries mostly suggesting clinical nutrition alternatives to their patients, keeping in mind their financial conditions. Hence, most pharmacies and dispensaries (in-house and retail) in emerging and third world countries do not maintain stocks of clinical nutrition products as two-third of the world population belong to the third world countries. This is restraining the growth of the Asia-Pacific clinical nutrition market. The other factor, such as heterogenous nature of government coverage/reimbursement across countries and imprecise perception about clinical nutrition is also hindering the growth of the market.

China Lead the Market in Asia-Pacific Region

The China clinical nutrition market holds the largest market share in 2017 in Asia-Pacific region due to the presence of high quality healthcare system and the majority of Asian countries are still developing with countries, like India, which in-spite of having good GDP per capita, are facing huge income disparities. This condition is leading to poor affordability of proper nutrition to most people. This chronic malnutrition is the major contributor to the growth of the clinical nutrition market in these regions.

Key Developments in the Market:

  • October 2017 – ABBOTT has acquired the Alere
  • July 2017 – Baxter has acquired the Claris Injectables, expanding the injectable medicines portfolio
Major Players: ABBOTT NUTRITION, NESTLE HEALTH SCIENCE, BAXTER HEALTHCARE, BRAUN MELSUNGEN AG, NUTRICIA, MEAD JOHNSON, PERRIGO COMPANY PLC, and FRESENIUS KABI, among others.

Reasons to Purchase this Report
  • Current and future Asia-Pacific clinical nutrition market outlook in the developed and emerging markets
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness fastest growth during the forecast period
  • Identifying the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet ((in Excel).
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;